Amarantus Bioscience Holdings Inc (AMBS)

[Chelby84]

News for 'AMBS' - (Amarantus Calls on BD Biosciences for Development of Alzheimer's Diagnostic)


Jun 18, 2013 (Close-Up Media via COMTEX) -- Amarantus BioScience Holdings,
Inc., a biotechnology company discovering and developing treatments and
diagnostics for diseases associated with neurodegeneration and apoptosis,
announced it has signed a laboratory services agreement with BD Biosciences, a
segment of BD (Becton, Dickinson and Company), a global medical technology
company, under which BD's BD Biosciences Custom Technology Team will perform
sample analysis on Amarantus' LymPro Test for Alzheimer's disease.

"The LymPro Test is potentially the first available blood test for Alzheimer's
disease," said Gerald E. Commissiong, President & CEO of Amarantus. "With this
agreement, we expect to have initial data available in the third quarter of
2013, and now have the capabilities required to place LymPro on a path for
commercialization in 2014."

According to a release, Amarantus and BD Biosciences will be focused on
verifying the analytical performance characteristics of LymPro necessary to
achieve reproducibility of the assay. Over time, Amarantus expects to execute
multiple clinical studies and begin worldwide sales of LymPro as a diagnostic
blood test for Alzheimer's disease.

Amarantus is a development-stage biotechnology company founded in January 2008.

More information:

Amarantus.com